Compare BPRN & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BPRN | KRMD |
|---|---|---|
| Founded | 2007 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.3M | 195.7M |
| IPO Year | 2022 | 2019 |
| Metric | BPRN | KRMD |
|---|---|---|
| Price | $35.67 | $4.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 7.5K | ★ 160.0K |
| Earning Date | 04-24-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | ★ 74.84 | 53.85 |
| EPS | ★ 2.71 | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | $9.96 | $20.32 |
| Revenue Next Year | $6.13 | $17.37 |
| P/E Ratio | $13.34 | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $27.25 | $2.08 |
| 52 Week High | $37.99 | $6.61 |
| Indicator | BPRN | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 61.72 | 41.82 |
| Support Level | $35.54 | $4.08 |
| Resistance Level | $36.83 | $4.34 |
| Average True Range (ATR) | 0.70 | 0.20 |
| MACD | 0.29 | 0.02 |
| Stochastic Oscillator | 86.53 | 48.94 |
Princeton Bancorp Inc is a full-service financial institution providing personal and business banking services, including checking and savings accounts, as well as a range of lending products such as residential, commercial, construction, and consumer loans, including home equity loans and lines of credit. The Bank operates branches and conducts loan origination activities in areas of the New York City metropolitan area. Its loan portfolio is segmented into commercial real estate (including owner-occupied, non-owner-occupied, and multi-family properties), construction loans (mainly for residential developments), commercial and industrial loans (for business purposes), residential real estate loans (secured by one-to-four family properties), and consumer/HELOC loans.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.